THIS WEBSITE IS FOR BUSINESS & INDUSTRY PARTNERS. FOR CONSUMER PRODUCTS VISIT : BLIS Probiotics >
The latest updates on our probiotic developments and news.
Periodontal disease affects nearly half of adults worldwide and remains one of the leading causes of tooth loss. Traditionally, treatment has focused
If you’ve ever had braces (or cared for someone who has), you know that maintaining fresh breath can become a real challenge.
New clinical data reveals how a targeted oral probiotic can deliver a breakthrough solution to a common problem—bad breath during orthodontic treatment.
Gum disease (periodontitis) is one of the most prevalent chronic health conditions globally — yet it often goes undetected until it’s advanced.
Scientific innovation is a team effort, and at BLIS, we’re proud to have a diverse group of scientists driving our research forward.
Our whitepaper delves into the science of probiotics and their role in reshaping the way we manage autoimmune health.
We’re proud to announce our support for the IPA World Congress + Probiota 2025, taking place February 5–7 in Copenhagen.
Recent research highlights a growing connection between oral health and systemic diseases, including cognitive, cardiovascular, and even fertility issues. Maintaining periodontal health is crucial for overall wellbeing, potentially lowering the risk of severe conditions such as Alzheimer’s, heart disease, and diabetes.
Meet us at SupplySide West 2024 in Las Vegas! Connect with our team to learn more about our advanced probiotic strains for oral, throat and immune health.
Meet us at Vitafoods Asia 2024 where we will be presenting our latest probiotic innovations and clinical research.
Oral health is often thought of as simply looking after your teeth and gums, but new research has uncovered the bi-directional relationship between the oral microbiome and systemic disease.
One of the most common and painful side effects of cancer treatment is mouth sores, medical known as oral mucositis, affecting a significant percentage of patients undergoing chemotherapy and radiotherapy. Recent studies have highlighted the potential of BLIS K12™ in providing much-needed relief for this condition.
